The global prefilled syringes devices market size was valued at USD 7.2 billion in 2015 and is projected to grow at a CAGR of 11.2% over the forecast period. The growing demand for patient safety measures and increasing efforts of healthcare professionals to reduce hospital errors are the principal factors driving the growth of the market. The fast-paced development of feature-rich devices with underlying technological advancements enabling safer and convenient self-injections for patients is expected to fuel the industry growth during the forecast period.
Prefilled injecting devices provide a simpler way to perform injection procedures as compared to other traditional ways. For healthcare practitioners, prefilled devices help save time and effort while preparing injection doses. In addition, the wastage of active pharmaceutical ingredients while transferring solutions from vials to syringe as well as manual and device-based measuring errors are reduced significantly with the use of prefilled syringes.
Japan prefilled syringes market, by material, 2014-2025, (USD Million)
Due to the numerous advantages offered, the companies ask for a premium price for the drugs sold in prefilled devices. Thus, pharmaceutical companies offer these devices as a pricing strategy to create price differentiation amongst their products.
On the other hand, injecting-device manufacturers, as well as companies providing contract filling services are focusing on developing technologies that will enable the reduction in material and procedure costs incurred in filling these injecting devices. This is resulting in decreased prices of prefilled syringes, which is favoring market expansion.
Disposable segment dominated the global market in 2015. High preference for patient safety leads to increased usage of disposable devices in hospitals and home care settings, which minimizes contamination risks due to multiple uses by different users. The disposable segment is expected to dominate throughout the forecast period owing to its increased application.
The reusable syringes segment, however, is expected to exhibit the fastest growth rate during the forecast period. Newly introduced auto-injectors such as i-Pen by Haselmeier AG and VigiPen by VigiHealth are equipped with technologies that connect these devices with patient health record systems. Such devices are mostly reusable and would exhibit the highest growth rate.
Based on material used to manufacture syringes, the report is segmented into glass and plastic syringes. Glass segment dominated the market in 2015. Whereas, the latter segment is expected to overtake the former during the later phase of the forecast period and dominate with a larger share in 2025.
The dominance of the plastic segment is mainly attributed to clarity and inertness of plastic-based products. These properties increase the level of safety by maintaining the purity of the content stored. As a result, these devices are getting popular among the physicians in order to reduce the number of hospital errors. Additionally, plastic syringes reduce the overall cost of the dose.
Diabetes segment captured the largest share in 2015. Large patient base and growing prevalence of diabetes is expected to maintain the dominance of the segment throughout the forecast period. Diabetes segment is followed by the anaphylaxis segment. Strategic marketing techniques, such as public awareness campaigns and price discrimination approach, implemented by Mylan for its patent-protected device, EpiPen, which is essentially a prefilled syringe containing epinephrine, is resulting in the revenue generation of the anaphylaxis application segment. These devices serve as a great tool for storage of vaccines and other biotech drugs, which are unstable and are prone to change their properties while transferring from vials to syringes.
A number of biotech companies are trying to reduce the cost to patient through the launch of self-administration auto-injector devices that bypass healthcare professionals. Thus, vaccines and other biotech drugs segment, including monoclonal antibodies, hormones, blood proteins, and amino acids, are expected to exhibit the significant growth during the forecast period.
Distribution Channel Insights
Three principal distribution channels include hospitals, mail-order pharmacies, and ambulatory surgery centers. High usage of prefilled syringes in emergency rooms and operation theaters is the prime factor driving the growth of the hospital segment.
The introduction of innovative designs to cater treatment need for chronic diseases, such as diabetes and rheumatoid arthritis, are expected to drive the mail order pharmacies segment significantly. Additionally, the mail order pharmacies help in reducing a significant cost to the customers. Thus, the demand for mail order pharmacies is anticipated to remain high during the forecast period.
Global prefilled syringes market, by distribution channel, 2015
In terms of region, Europe captured the largest market share in 2015. The presence of a large number of key players and high adoption of prefilled syringes in Europe are the factors driving the dominance of the region. Growing adoption in the U.S. and development of advanced technologies are the factors expected to fuel the industry growth in North America. Asia Pacific is expected to grow at the second fastest growth rate owing to the presence of untapped market in this region.
In addition, growing vaccines and biotech drugs space in this part of the world is anticipated to spur the demand for prefilled devices in Asia Pacific. Furthermore,rapidly booming medical tourism industry in the countries such as India, Thailand, and Brazil owing to the availability of advanced healthcare facilities and services at cheaper cost, presence of skilled medical professionals and favorable government policies is likely to push the market growth.
Some of the key players include injector manufacturers such as Gerresheimer AG, SCHOTT, Unilife Corporation, Nipro Medical Corporation, Owen Mumford, and Haselmeier AG. These companies focus on deploying investments to increase their manufacturing capabilities and hence maintain their company share.
Companies such as SHL Group, Becton, Dickinson & Company, and Datwyler Pharma Packaging have the expertise to design and develop novel devices with customization options to suit the drug type. Biotech companies such as Health Biotech Limited and VigiHealth are also increasingly marketing drug-specific prefilled injectors. In addition, the growing demand for these devices is attracting various new entrants to provide contract services for filling of syringes. The industry for syringe manufacturing is heading toward consolidation. However, new entrants can easily enter this space with advanced and innovative drug filling technologies to launch new and improved designs.
Base year for estimation
Actual estimates/Historical data
Revenue in USD Million & CAGR from 2016 to 2025
North America, Europe, Asia Pacific, Latin America & MEA
U.S., Canada, UK, Germany, Japan, China, Brazil, Mexico, South Africa
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization
Segments Covered in the Report
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the prefilled syringes market on the basis of type, material, application, distribution channel, and region:
Type Outlook (Revenue, USD Million; 2014-2025)
Material Outlook (Revenue, USD Million; 2014-2025)
Application Outlook (Revenue, USD Million; 2014-2025)
Others (Vaccines and other biotech drugs)
Distribution Channel Outlook (Revenue, USD Million; 2014-2025)
Mail Order Pharmacies
Ambulatory Surgery Centers
Regional Outlook (Revenue, USD Million; 2014-2025)
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.